Polymorphisms, genomic imprinting and cancer susceptibility

Mutation Research - Reviews in Mutation Research

Volumn 436, Issue 1, 1999, Pages 59-67

  Pulford, David J ^a,b   Falls, J Greg ^b   Killian, J Keith ^b   Jirtle, Randy L ^b  

^a ASTRAZENECA   (United Kingdom)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cancer susceptibility; Genomic imprinting; M6P IGF2R; Oncogene; Polymorphism; Tumor suppressor gene

Indexed keywords

CANCER SUSCEPTIBILITY; CARCINOGENESIS; GENE CONTROL; GENETIC POLYMORPHISM; GENOME IMPRINTING; HUMAN; NEPHROBLASTOMA; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0032898879     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(98)00018-0     Document Type: Article

References (79)

1. Weinberg R.A. The molecular basis of oncogenes and tumor suppressor genes. Ann. NY Acad. Sci. 758:1995;331-338.
2. Knudson A.G. Hereditary predisposition to cancer. Ann. NY Acad. Sci. 833:1997;58-67.
3. Caporaso N., Goldstein A. Cancer genes: single and susceptibility: exposing the difference. Pharmacogenetics. 5:1995;59-63.
4. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 30:1995;445-600.
5. Miller M.S., McCarver D.G., Bell D.A., Eaton D.L., Goldstein J.A. Genetic polymorphisms in human drug metabolic enzymes. Fundam. Appl. Toxicol. 40:1997;1-14.
6. Barlow D.P. Gametic imprinting in mammals. Science. 270:1995;1610-1613.
7. Laird P.W., Jaenisch R. The role of DNA methylation in cancer genetics and epigenetics. Annu. Rev. Genet. 30:1996;441-464.
8. Zingg J.-M., Jones P.A. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis. 18:1997;869-882.
9. Tycko B. DNA methylation in genomic imprinting. Mutat. Res. 386:1997;103-105.
10. Xu Y., Goodyer C.G., Deal C., Polychronakos C. Functional polymorphism in the parental imprinting of the human IGF2R gene. Biochem. Biophys. Res. Commun. 197:1993;747-754.
11. Vu T.H., Hoffman A.R. Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature. 371:1994;714-717.
12. Jinno Y., Yun K., Nishiwaki K., Kubota T., Ogawa O., Reeve A.E., Nikawa N. Mosaic and polymorphic imprinting of the WT1 gene in humans. Nat. Genet. 6:1994;305-309.
13. Okamoto K., Morison I.M., Taniguchi T., Reeve A.E. Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms' tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 94:1997;5367-5371.
14. Dao D., Frank D., Qian N., O'Keefe D., Vosatka R.J., Walsh C.P., Tycko B. IMPT1, an imprinted gene similar to polyspecific transporter and multi-drug resistance genes. Hum. Mol. Genet. 7:1998;597-608.
15. Peterson K., Sapienza C. Imprinting the genome: imprinted genes, imprinting genes, and a hypothesis for their interaction. Annu. Rev. Genet. 27:1993;7-31.
16. Tycko B., Trasler J., Bestor T. Genomic imprinting: gametic mechanisms and somatic consequences. J. Androl. 18:1997;480-486.
17. Surani M.A. Imprinting and the initiation of gene silencing in the germ line. Cell. 93:1998;309-312.
18. Bestor T.H., Tycko B. Creation of genomic methylation patterns. Nat. Genet. 12:1996;363-367.
19. Haig D., Graham C. Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell. 64:1991;1045-1046.
20. DeChiara T.M., Efstratiadis A., Robertson E.J. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature. 345:1990;78-80.
21. DeChiara T.M., Robertson E.J., Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell. 64:1991;849-859.
22. Barlow D.P., Stöger R., Herrmann B.G., Saito K., Schweifer N. The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature. 349:1991;84-87.
23. Kornfeld S. Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu. Rev. Biochem. 61:1992;307-330.
24. Miyoshi N., Kuroiwa Y., Kohda T., Shitara H., Yonekawa H., Kawabe T., Hasegawa H., Barton S.C., Surani M.A., Kaneko-Ishino T., Ishino F. Identification of the Meg1/Grb10 imprinted gene on mouse proximal chromosome 11, a candidate for the Silver-Russell syndrome gene. Proc. Natl. Acad. Sci. U.S.A. 95:1998;1102-1107.
25. Jaenisch R., Schnieke A., Harbers K. Treatment of mice with 5-azacytidine efficiently activates silent retroviral genomes in different tissues. Proc. Natl. Acad. Sci. U.S.A. 82:1985;1451-1455.
26. Hendrich B.D., Huntington F.W. Epigenetic regulation of gene expression: the effect of altered chromatin structure from yeast to mammals. Hum. Mol. Genet. 4:1995;1765-1777.
27. Feil R., Kelsey G. Genomic imprinting: a chromatin connection. Am. J. Hum. Genet. 61:1997;1213-1219.
28. Razin A., Cedar H. DNA methylation and genomic imprinting. Cell. 77:1994;473-476.
29. Li E., Beard C., Jaenisch R. Role of DNA methylation in genomic imprinting. Nature. 366:1993;362-365.
30. Chung W.Y., Yuan L., Feng L., Hensle T., Tycko B. Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors. Hum. Mol. Genet. 5:1996;1101-1108.
31. Barletta J.M., Rainier S., Feinberg A.P. Reversal of loss of imprinting in tumor cells by 5-aza-2′-deoxycytidine. Cancer Res. 57:1997;48-50.
32. Hu J.-F., Nguyen P.H., Pham N.V., Vu T.H., Hoffman A.R. Modulation of Igf2 genomic imprinting in mice induced by 5-azacytidine, an inhibitor of DNA methylation. Mol. Endocrinol. 11:1997;1891-1898.
33. Varela-Moreiras G., Alonso-Aperte E., Rubio M., Gasso M., Deulofeu R., Alvarez L., Caballeria J., Rodes J., Mato J.M. Carbon tetrachloride-induced hepatic injury is associated with global DNA hypomethylation and homocysteinemia: effect of S-adenosylmethionine treatment. Hepatology. 22:1995;1310-1315.
34. Mass M.J., Wang L. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat. Res. 386:1997;263-277.
35. Varela-Moreiras G., Ragel C., Perez de Miguelsanz J. Choline deficiency and methotrexate treatment induces marked but reversible changes in hepatic folate concentrations, serum homocysteine and DNA methylation rates in rats. J. Am. Coll. Nutr. 14:1995;480-485.
36. Squire J., Weksberg R. Genomic imprinting in tumours. Semin. Cancer Biol. 7:1996;41-47.
37. De Souza A.T., Yamada T., Mills J.J., Jirtle R.L. Imprinted genes in liver carcinogenesis. FASEB J. 11:1997;60-67.
38. Reik W. Genetic imprinting: the battle of the sexes rages on. Exp. Physiol. 81:1996;161-172.
39. Lalande M. Parental imprinting and human disease. Annu. Rev. Genet. 30:1996;173-195.
40. Keverne E.B. Genomic imprinting in the brain. Curr. Opin. Neurobiol. 7:1997;463-468.
41. Skuse D.H., James R.S., Bishop D.V.M., Coppin B., Dalton P., Aamodt-Leeper G., Bacarese-Hamilton M., Creswell C., McGurk R., Jacobs P.A. Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. Nature. 387:1997;705-708.
42. Chorney M.J., Chorney K., Seese N., Owen M.J., Daniels J., McGuffin P., Thompson L.A., Detterman D.K., Benbow C., Lubinski D., Eley T., Plomin R. A quantitative trait locus associated with cognitive ability in children. Psych. Sci. 9:1998;159-166.
43. Linder D., McCaw B.K., Hecht F. Parthenogenetic origin of benign ovarian teratomas. New Engl. J. Med. 292:1975;63-66.
44. Wake N., Fujino T., Hoshi S., Shinkai N., Sakai K., Kato H., Hashimoto M., Yasuda T., Yamada H., Ichinoe K. The propensity to malignancy of dispermic heterozygous moles. Placenta. 8:1987;319-326.
45. Katz F., Webb D., Gibbons B., Reeves B., McMahon C., Cheselles J., Mitchell C. Possible evidence for genomic imprinting in childhood acute myeloblastic leukaemia associated with monosomy for chromosome 7. Br. J. Haematol. 80:1992;332-336.
46. Toguchida J., Ishizaki K., Sasaki M.S., Nakamura Y., Ikenaga M., Kato M., Sugimot M., Kotoura Y., Yamamuro T. Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma. Nature. 338:1989;156-158.
47. Caron H., van Sluis P., van Hoeve M., de Kraker J., Bras J., Slater R., Mannens M., Voute P.S., Westerveld A., Versteeg R. Allelic loss of chromosome 1p36 in neuroblastoma is preferential maternal origin and correlates with N-myc amplification. Nat. Genet. 4:1993;187-190.
48. Scrable H., Cavenne W., Ghavimi F., Lovell M., Morgan K., Sapienza C. A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc. Natl. Acad. Sci. U.S.A. 86:1989;7480-7484.
49. B. Tycko, Genomic imprinting in Wilms' tumor, Med. Ped. Oncol., 1996.
50. van der Mey A.G.L., Maaswinkel-Mooy P.D., Cornelisse C.J., Schmidt P.H., van de Kamp J.J.P. Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory. Lancet. 2:1989;1291-1294.
51. Feinberg A.P., Rainier S., DeBaun M.R. Genomic imprinting, DNA methylation, and cancer. J. Natl. Cancer Inst. Monographs. 17:1995;21-26.
52. Huff V., Saunders G.F. Wilms' tumor genes. Biochim. Biophys. Acta. 1155:1993;295-306.
53. Rainier S., Johnson L.A., Dobry C.J., Ping A.J., Grundy P.E., Feinberg A.P. Relaxation of imprinted genes in human cancer. Nature. 362:1993;747.
54. Ogawa O., Eccles M.R., Szeto J., McNoe L.A., Yun K., Maw M.A., Smith P.J., Reeve A.E. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature. 362:1993;749-751.
55. Rogler C.E., Yang D., Rossetti L., Donohoe J., Alt E., Chang C.J., Rosenfeld R., Neely K., Hintz R. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J. Biol. Chem. 269:1994;13779-13784.
56. Bates P., Fisher R., Ward A., Richardson L., Hill D.J., Graham C.F. Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II). Br. J. Cancer. 72:1995;1189-1193.
57. Feinberg A.P., Kalikin L.M., Johnson L.A., Thompson J.S. Loss of imprinting in human cancer. CSH Symp. Quant. Biol. 59:1994;357-364.
58. Webber A.L., Ingram R.S., Levorse J.M., Tilghman S.M. Location of enhancers is essential for the imprinting of H19 and Igf2 genes. Nature. 391:1998;711-715.
59. Hao Y., Crenshaw T., Moulton T., Newcomb E., Tycko B. Tumor-suppressor activity of H19. Nature. 365:1993;764-767.
60. Leighton P.A., Ingram R.S., Eggenschwiler J., Efstratiatis A., Tilghman S.M. Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature. 375:1995;34-39.
61. Rauscher F.J. 3d, The WT1 Wilms' tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J. 7:1993;896-903.
62. KIP2 and its reduced expression in Wilms' tumors. Hum. Mol. Genet. 5:1996;783-788.
63. Kondo M., Matsuoka S., Uchida K., Osada H., Nagatake M., Takagi K., Harper J.W., Takahashi T., Elledge S.J., Takahashi T. Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5. Oncogene. 12:1996;1365-1368.
64. Yamada T., De Souza A.T., Finkelstein S., Jirtle R.L. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 94:1997;10351-10355.
65. Hu J.F., Vu T.H., Hoffman A.R. Promoter-specific modulation of insulin-like growth factor II genomic imprinting by inhibitors of DNA methylation. J. Biol. Chem. 271:1996;18253-18262.
66. Hu J.F., Oruganti H., Vu T.H., Hoffman A.R. Tissue-specific imprinting of the mouse insulin-like growth factor II receptor gene correlates with differential allele-specific DNA methylation. Mol. Endocrinol. 12:1998;220-232.
67. Korner C., Nurnberg B., Uhde M., Braulke T. Mannose 6-phosphate/insulin-like growth factor II receptor fails to interact with G-proteins. J. Biol. Chem. 270:1995;287-295.
68. De Souza A.T., Hankins G.R., Washington M.K., Fine R.L., Orton T.C., Jirtle R.L. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene. 10:1995;1725-1729.
69. De Souza A.T., Hankins G.R., Washington M.K., Orton T.C., Jirtle R.L. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat. Genet. 11:1995;447-449.
70. Mills J.J., Falls J.G., De Souza A.T., Jirtle R.L. Imprinted M6p/Igf2 receptor is mutated in rat liver tumors. Oncogene. 16:1998;2797-2802.
71. Hankins G.R., De Souza A.T., Bentley R.C., Patel M.R., Marks J.R., Iglehart J.D., Jirtle R.L. M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene. 12:1996;2003-2009.
72. Souza R.F., Appel R., Yin J., Wang S., Smolinski K.N., Abraham J.M., Zou T.-T., Shi Y.-Q., Lei J., Cottrell J., Cymes K., Biden K., Simms L., Leggett B., Lynch P.M., Frazier M., Powell S.M., Harpaz N., Sugimura H., Young J., Meltzer S.J. The insulin-like growth factor II receptor gene is a target of microsatellite instability in human gastrointestinal tumours. Nat. Genet. 14:1996;255-257.
73. Ouyang H., Shiwaku H.O., Hagiwara H., Miura K., Abe T., Kato Y., Ohtani H., Shiiba K., Souza R.F., Meltzer S.J., Horii A. The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum. Cancer Res. 57:1997;1851-1854.
74. Chappell S.A., Walsh T., Walker R.A., Shaw J.A. Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor correlates with poor differentiation in early breast carcinomas. Br. J. Cancer. 76:1997;1558-1561.
75. Wang Z.Q., Fung M.R., Barlow D.P., Wagner E.F. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature. 372:1994;464-467.
76. Smrzka O.W., Fae I., Stöger R., Kurzbauer R., Fischer G.F., Henn T., Weith A., Barlow D.P. Conservation of a maternal-specific methylation signal at the human IGF2R locus. Hum. Mol. Genet. 4:1995;1945-1952.
77. Ogawa O., McNoe L.A., Eccles M.R., Morison I.M., Reeve A.E. Human insulin-like growth factor type I and type II receptors are not imprinted. Hum. Mol. Genet. 2:1993;2163-2165.
78. Kalscheuer V.M., Mariman E.C., Schepens M.T., Rehder H., Ropers H.-H. The insulin-like growth factor type-2 receptor gene is imprinted in the mouse but not in humans. Nat. Genet. 5:1993;74-78.
79. Xu Y.Q., Grundy P., Polychronakos C. Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor. Oncogene. 14:1997;1041-1046.